The Georgia Supreme Court ruled that a woman's claims against several hair-relaxer companies over alleged health risks can ...
Zacks Investment Research on MSN
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth
Hologic HOLX continues to experience strong momentum across its GYN Surgical portfolio, underscoring the increasing global focus on women’s health. The company’s investments in commercial and market ...
Six-month outcomes from the Ventricular Catheter Ablation Study, the first-in-human evaluation of its FieldForce Ablation ...
As many as 80% of women will have uterine fibroids in their lifetime. Too many of them will undergo a hysterectomy, experts say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results